glp-1 and tamoxifen Receptor Agonist Use Weight Change in Patients With Breast Cancer GLP-1 Receptor Agonists in Breast

That second use case is driving rapid product launches, but it should not be confused with proven food-based enhancement of endogenous GLP-1 physiology

Ambrosone CB, Zirpoli GR, Hutson AD, McCann WE, McCann SE, Barlow WE, Kelly KM, Cannioto R, Sucheston-Campbell LE, Hershman DL, Unger JM, Moore HCF, Stewart JA, Isaacs C, Hobday TJ, Salim M, Hortobagyi GN, Gralow JR, Budd GT, Albain KS

How does the Precision Peptide Genetic Test relate to triglyceride response

Published Phase 2 and Phase 3 trials for both molecules enrol as monotherapy (with or without background T2D therapy such as metformin or insulin)

Khunti K, Chatterjee S, Gerstein HC, Zoungas S, Davies MJ